BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8753320)

  • 1. [Substance P].
    Matsubayashi S; Tamai H; Yanaihara N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():631-5. PubMed ID: 8753320
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of increased levels of substance P in obese children.
    Baroncelli GI; Bertelloni S; Buggiani B; Papini A; Gualtieri M; Saggese G
    Funct Neurol; 1989; 4(2):183-4. PubMed ID: 2472310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma substance P levels in fibrositis.
    Reynolds WJ; Chiu B; Inman RD
    J Rheumatol; 1988 Dec; 15(12):1802-3. PubMed ID: 2466119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the study of the molecular neurobiology of substance P].
    Li HS; Zhao ZQ
    Sheng Li Ke Xue Jin Zhan; 1994 Jan; 25(1):37-41. PubMed ID: 7521061
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity.
    Chorev M; Roubini E; Gilon C; Selinger Z
    Biopolymers; 1991 May; 31(6):725-33. PubMed ID: 1718472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
    Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
    Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors and antagonists for substance P and related peptides.
    Regoli D; Boudon A; Fauchére JL
    Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased serum substance P concentration in the acute phase of intracranial hemorrhage.
    Sakaida H; Tanemura H; Yoshikawa T; Taki W
    J Am Geriatr Soc; 2005 Apr; 53(4):734-5. PubMed ID: 15817032
    [No Abstract]   [Full Text] [Related]  

  • 9. Substance P in the serum of patients with rheumatoid arthritis.
    Anichini M; Cesaretti S; Lepori M; Maddali Bongi S; Maresca M; Zoppi M
    Rev Rhum Engl Ed; 1997 Jan; 64(1):18-21. PubMed ID: 9051855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurokinin receptors. The role of substance P in inflammatory processes].
    Hrabec Z; Hrabec E
    Postepy Biochem; 1992; 38(1):28-32. PubMed ID: 1380702
    [No Abstract]   [Full Text] [Related]  

  • 11. Concordance between substance P levels and antiemetic guidelines.
    Higa GM; Auber ML; Altaha R; Kurian S; Hobbs G
    J Support Oncol; 2009; 7(4):138-42. PubMed ID: 19731580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Substance P--perioperative plasma level in patients with intracranial tumors--a first pilot study].
    Röding T; Schädlich M
    Anaesthesiol Reanim; 1988; 13(3):177-82. PubMed ID: 2463841
    [No Abstract]   [Full Text] [Related]  

  • 13. Substance P: elimination from the circulation of the rat after intravenous injection.
    Heinrich N; Rathsack R; Berger H; Mehlis B
    Pharmazie; 1982 Nov; 37(11):808. PubMed ID: 6187029
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substance P--results of observing the course of plasma levels during heart surgery].
    Jende S; Schädlich M; Krug G
    Anaesthesiol Reanim; 1990; 15(2):95-9. PubMed ID: 1692707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substance P in human plasma and the effect of anesthetics (author's transl)].
    Sasaki H; Naito E; Noguchi R; Maruyama Y; Matsuki M; Shimoji K; Ito S
    Masui; 1981 Jul; 30(7):656-63. PubMed ID: 6172608
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorescence, CD, and NMR studies on spantide, a bombesin and substance P antagonist.
    Di Bello C; Scatturin A; D'Auria G; Gargiulo M; Paolillo L; Trivellone E; De Castiglione R
    Biopolymers; 1991 May; 31(6):643-52. PubMed ID: 1718471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a biotinylated analog of substance P for use as a receptor probe.
    Anton PA; Reeve JR; Vidrich A; Mayer E; Shanahan F
    Lab Invest; 1991 May; 64(5):703-8. PubMed ID: 1709427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two domains of the beta subunit of neuronal nicotinic acetylcholine receptors contribute to the affinity of substance P.
    Stafford GA; Oswald RE; Figl A; Cohen BN; Weiland GA
    J Pharmacol Exp Ther; 1998 Aug; 286(2):619-26. PubMed ID: 9694912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of immunoreactive beta-endorphin and substance P in patients undergoing surgery under general vs spinal anaesthesia.
    Janicki PK; Erskine R; van der Watt ML
    Horm Metab Res; 1993 Feb; 25(2):131-3. PubMed ID: 7681422
    [No Abstract]   [Full Text] [Related]  

  • 20. [The behavior of substance P concentration in rat plasma in the acute single- and combined-actions of trichloroethylene and ethanol].
    Fendius RR; Gutewort T; Hinz G
    Pharmazie; 1991 Mar; 46(3):215-6. PubMed ID: 1715586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.